Jupiter Asset Management LTD Biomarin Pharmaceutical Inc Transaction History

Jupiter Asset Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$71.72 - $91.47 $1.68 Million - $2.15 Million	-23,471 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$74.77 - $85.47 $1.02 Million - $1.16 Million	13,598 Added 137.73%	23,471 $1.81 Million
Q2 2021 Aug 10, 2021	BUY	$75.51 - $84.79 $745,510 - $837,131	9,873 New	9,873 $824,000
Q1 2021 May 12, 2021	SELL	$74.73 - $90.69 $404,737 - $491,177	-5,416 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$72.61 - $90.2 $393,255 - $488,523	5,416 New	5,416 $474,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Jupiter Asset Management LTD with notifications on news.